| MEN N = 2,007 | WOMEN N = 4,380 | ||||||
---|---|---|---|---|---|---|---|---|
Indicator markers | Prevalence of marker | Interval | Prevalence of marker | Interval | ||||
(days before RA code) | (days before RA code) | |||||||
 | N | % | Median | IQR | N | % | Median | [IQR] |
  Inflammatory arthritis diagnosis | 237 | 11.8 | 79 | [22–154] | 469 | 10.7 | 71 | [17–175] |
  Synovitis | 65 | 3.2 | 66 | [22–153] | 114 | 2.6 | 84 | [28–188] |
  RhF test | 1,114 | 55.5 | 49 | [9–137] | 2,397 | 54.7 | 43 | [6–127] |
  DMARD prescription (not including steroids) | 681 | 33.9 | 45 | [0–309] | 1353 | 30.9 | 71 | [0–326] |
  Referral to Rheum | 811 | 40.4 | 66 | [13–183] | 1642 | 37.5 | 70 | [11–193] |
  Joint sign or symptom | 1032 | 51.4 | 132 | [54.5-245] | 2202 | 50.3 | 133.5 | [52–259] |
Keywords | Prevalence of keyword | Interval | Prevalence of keyword | Interval | ||||
(days before RA code) | (days before RA code ) | |||||||
 | N | % | Median | IQR | N | % | Median | IQR |
  Rheumatoid A | 590 | 29.4 | 37 | [0–121] | 1,262 | 28.8 | 28 | [0–122] |
  Positive RhF test | 911 | 45.4 | 49 | [7–136] | 2,033 | 46.4 | 47 | [7–151] |
  Inflammatory arthritis | 378 | 18.8 | 70 | [17–168] | 790 | 18.0 | 78 | [21–183] |
  Synovitis | 379 | 18.9 | 57 | [7–159] | 789 | 18.0 | 55 | [7–160] |